BCSF vs. MSDL, OBDE, CVII, TRIN, AACT, CION, DHHC, AIRJ, NETD, and UBSI
Should you be buying Bain Capital Specialty Finance stock or one of its competitors? The main competitors of Bain Capital Specialty Finance include Morgan Stanley Direct Lending (MSDL), Blue Owl Capital Co. III (OBDE), Churchill Capital Corp VII (CVII), Trinity Capital (TRIN), Ares Acquisition Co. II (AACT), CION Investment (CION), DiamondHead (DHHC), Montana Technologies (AIRJ), Nabors Energy Transition Corp. II (NETD), and United Bankshares (UBSI).
Morgan Stanley Direct Lending (NYSE:MSDL) and Bain Capital Specialty Finance (NYSE:BCSF) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment, community ranking and earnings.
In the previous week, Morgan Stanley Direct Lending and Morgan Stanley Direct Lending both had 1 articles in the media. Morgan Stanley Direct Lending's average media sentiment score of 0.84 beat Bain Capital Specialty Finance's score of 0.00 indicating that Bain Capital Specialty Finance is being referred to more favorably in the news media.
Bain Capital Specialty Finance received 57 more outperform votes than Morgan Stanley Direct Lending when rated by MarketBeat users.
Morgan Stanley Direct Lending pays an annual dividend of $2.00 per share and has a dividend yield of 8.9%. Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 10.2%. Morgan Stanley Direct Lending pays out 64.5% of its earnings in the form of a dividend. Bain Capital Specialty Finance pays out 84.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Morgan Stanley Direct Lending has higher revenue and earnings than Bain Capital Specialty Finance. Morgan Stanley Direct Lending is trading at a lower price-to-earnings ratio than Bain Capital Specialty Finance, indicating that it is currently the more affordable of the two stocks.
Morgan Stanley Direct Lending has a net margin of 62.34% compared to Morgan Stanley Direct Lending's net margin of 43.42%. Bain Capital Specialty Finance's return on equity of 12.87% beat Morgan Stanley Direct Lending's return on equity.
Morgan Stanley Direct Lending presently has a consensus price target of $21.92, suggesting a potential downside of 2.16%. Bain Capital Specialty Finance has a consensus price target of $16.33, suggesting a potential downside of 0.62%. Given Morgan Stanley Direct Lending's higher probable upside, analysts plainly believe Bain Capital Specialty Finance is more favorable than Morgan Stanley Direct Lending.
Summary
Morgan Stanley Direct Lending beats Bain Capital Specialty Finance on 9 of the 14 factors compared between the two stocks.
Get Bain Capital Specialty Finance News Delivered to You Automatically
Sign up to receive the latest news and ratings for BCSF and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BCSF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Bain Capital Specialty Finance Competitors List
Related Companies and Tools